TargetGene Biotechnologies ^{For Profit}

TargetGene is a company that aims to develop a therapeutic genome editing platform to cure cancer, genetic and heritable diseases, and autoimmune disorders. The company's TGEE platform is designed to overcome off-target cleavage, which is the most serious problem currently impeding therapeutic genome editing. TargetGene has accumulated valuable IP in the field and has a tightly knit team that is deeply passionate about bringing cures to patients. The company is focused on targeting heritable diseases, cancer, and immune disorders and has attracted three corporate strategic investors from its inception. Contact info: N/A